USD 12.43
↑ 0.01 (0.08%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| GOCO | 0.1 | 5.2 | 30.2 | 52.0 | 40.5 | -14.8 | -81.0 | -95.7 | -95.7 | -95.7 |
| S&P 500 | -1.4 | -1.9 | 0.9 | 5.8 | 10.5 | 30.3 | 25.3 | 88.0 | 187.3 | 33113.7 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | GOCO |
| name | GoHealth, Inc. |
| price | 12.43 |
| changes percentage | 0.0805 |
| change | 0.01 |
| day low | 12.27 |
| day high | 12.5 |
| year high | 16.44 |
| year low | 7.27 |
| market cap | 125039585 |
| price avg 50 | 10.2012 |
| price avg 200 | 10.590675 |
| exchange | NASDAQ |
| volume | 7470 |
| avg volume | 23398 |
| open | 12.48 |
| previous close | 12.42 |
| eps | -3.29 |
| pe | -3.78 |
| earnings announcement | 2025-03-13T04:00:00.000+0000 |
| shares outstanding | 10059500 |
| timestamp | 2024-11-15 17:22:23 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001808220 | |||
| revenue | 734671000 | 631675000 | 16.31 |
| gross profit | 575710000 | 444005000 | 29.66 |
| gross profit ratio | 0.78 | 0.7 | 11.49 |
| research and development expenses | 0 | -0.59 | 100.00 |
| operating expenses | 719608000 | 725142000 | -0.76 |
| interest income | 0 | 0 | NaN |
| interest expense | 69472000 | 57069000 | 21.73 |
| ebitda | 38674000 | -174135000 | 122.21 |
| ebitdaratio | 0.05 | -0.28 | 119.11 |
| operating income | -81681000 | -281137000 | 70.95 |
| operating income ratio | -0.11 | -0.45 | 75.02 |
| net income | -63257000 | -376384000 | 83.19 |
| net income ratio | -0.09 | -0.6 | 85.55 |
| eps | -7.19 | -44.57 | 83.87 |
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001808220 | |||
| revenue | 118292000 | 105870000 | 11.73 |
| gross profit | 94778000 | 58892000 | 60.94 |
| gross profit ratio | 0.8 | 0.56 | 44.04 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 137450000 | 125800000 | 9.26 |
| interest income | 0 | 0 | NaN |
| interest expense | 19086000 | 18096000 | 5.47 |
| ebitda | -42672000 | -14312000 | -198.16 |
| ebitdaratio | -0.36 | -0.14 | -166.85 |
| operating income | -42672000 | -40610000 | -5.08 |
| operating income ratio | -0.36 | -0.38 | 5.96 |
| net income | 15366000 | -25996000 | 159.11 |
| net income ratio | 0.13 | -0.25 | 152.90 |
| eps | 1.52 | -2.61 | 158.24 |
Revenue Growth: revenue increased to 118 million in 2024Q3 from 106 million in 2024Q2 representing a change of 11.73%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 95 million in 2024Q3 from 59 million in 2024Q2 representing a change of 60.94%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -43 million in 2024Q3 from -14 million in 2024Q2 representing a change of -198.16%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -43 million in 2024Q3 from -41 million in 2024Q2 representing a change of -5.08%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 15 million in 2024Q3 from -26 million in 2024Q2 representing a change of 159.11%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 1.52 in 2024Q3 from 1.52 in 2024Q2 representing a change of 158.24%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 137 million in 2024Q3 from 126 million in 2024Q2 representing a change of 9.26%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001808220 | |||
| total assets | 1499570000 | 1659290000 | -9.63 |
| total liabilities | 1093917000 | 1067589000 | 2.47 |
| total equity | 405653000 | 591701000 | -31.44 |
| cash and cash equivalents | 90809000 | 16464000 | 451.56 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | -1659290000 | 100.00 |
| total current assets | 476440000 | 414556000 | 14.93 |
| total non current assets | 1023130000 | 1244734000 | -17.80 |
| total current liabilities | 370013000 | 265455000 | 39.39 |
| total non current liabilities | 674602000 | 802134000 | -15.90 |
| common stock | 2000 | 2000 | 0.00 |
| retained earnings | -420280000 | -357023000 | -17.72 |
| total debt | 592351000 | 557421000 | 6.27 |
Total Assets: Total Assets decreased to 1,500 million in 2023 from 1,659 million in 2022 representing a change of -9.63%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 1,094 million in 2023 from 1,068 million in 2022 representing a change of 2.47%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 406 million in 2023 from 592 million in 2022 representing a change of -31.44%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 370 million in 2023 from 265 million in 2022 representing a change of 39.39%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -420 million in 2023 from -357 million in 2022 representing a change of -17.72%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 592 million in 2023 from 557 million in 2022 representing a change of 6.27%. This indicates an increase in overall debt burden.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 91 million in 2023 from 16 million in 2022 representing a change of 451.56%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 476 million in 2023 from 415 million in 2022 representing a change of 14.93%. This indicates a better liquidity position.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001808220 | |||
| total assets | 1341153000 | 1257075000 | 6.69 |
| total liabilities | 1129113000 | 929276000 | 21.50 |
| total equity | 345259000 | 327799000 | 5.33 |
| cash and cash equivalents | 35527000 | 14124000 | 151.54 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 0 | NaN |
| total current assets | 334043000 | 301172000 | 10.91 |
| total non current assets | 1007110000 | 955903000 | 5.36 |
| total current liabilities | 281971000 | 234038000 | 20.48 |
| total non current liabilities | 661900000 | 644138000 | 2.76 |
| common stock | 2000 | 2000 | 0.00 |
| retained earnings | -448717000 | -455492000 | 1.49 |
| total debt | 523060000 | 546104000 | -4.22 |
Total Assets: Total Assets increased to 1,341 million in 2024Q3 from 1,257 million in 2024Q2 representing a change of 6.69%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 345 million in 2024Q3 from 328 million in 2024Q2 representing a change of 5.33%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 36 million in 2024Q3 from 14 million in 2024Q2 representing a change of 151.54%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 334 million in 2024Q3 from 301 million in 2024Q2 representing a change of 10.91%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to -449 million in 2024Q3 from -455 million in 2024Q2 representing a change of 1.49%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 523 million in 2024Q3 from 546 million in 2024Q2 representing a change of -4.22%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 1,129 million in 2024Q3 from 929 million in 2024Q2 representing a change of 21.5%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 282 million in 2024Q3 from 234 million in 2024Q2 representing a change of 20.48%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001808220 | |||
| net change in cash | 74345000 | -67897000 | 209.50 |
| operating cash flow | 109141000 | 60904000 | 79.20 |
| free cash flow | 95409000 | 47392000 | 101.32 |
| capital expenditure | -13732000 | -13512000 | -1.63 |
| depreciation and amortization | 105748000 | 107002000 | -1.17 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 19549000 | 27142000 | -27.98 |
| accounts payables | 2556000 | -28218000 | 109.06 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -13732000 | -13512000 | -1.63 |
| net cash used for investing activites | -13732000 | -13512000 | -1.63 |
| debt repayment | -15336000 | -160270000 | 90.43 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -2295000 | -345000 | -565.22 |
| dividends paid | -3566000 | 0 | NaN |
| net cash used provided by financing activities | -21106000 | -115051000 | 81.66 |
| cash at end of period | 90809000 | 16464000 | 451.56 |
| accounts receivables | 125092000 | 243848000 | -48.70 |
| cash at beginning of period | 16464000 | 84361000 | -80.48 |
Net Change in Cash: Net Change in Cash increased to 74 million in 2023 from -68 million in 2022 representing a change of 209.5%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 109 million in 2023 from 61 million in 2022 representing a change of 79.2%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 95 million in 2023 from 47 million in 2022 representing a change of 101.32%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -14 million in 2023 from -14 million in 2022 representing a change of -1.63%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 20 million in 2023 from 27 million in 2022 representing a change of -27.98%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 3 million in 2023 from 28 million in 2022 representing a change of 109.06%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables decreased to 125 million in 2023 from 244 million in 2022 representing a change of -48.7%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Dividends Paid: Dividends Paid decreased to -4 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001808220 | |||
| operating cash flow | -3171000 | -45552000 | 93.04 |
| free cash flow | -7424000 | -48254000 | 84.61 |
| capital expenditure | -4253000 | -2702000 | -57.40 |
| depreciation and amortization | 26418000 | 26298000 | 0.46 |
| deferred income tax | 40000 | -40000 | 200.00 |
| stock based compensation | 2859000 | 1892000 | 51.11 |
| accounts receivables | -88092000 | 23853000 | -469.31 |
| accounts payables | 4619000 | 3045000 | 51.69 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 17536000 | 0 | NaN |
| investments in property plant and equipment | -4253000 | -2702000 | -57.40 |
| net cash used for investing activites | 13283000 | -2702000 | 591.60 |
| debt repayment | 0 | -50000000 | 100.00 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 1335000 | -393000 | 439.69 |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 11271000 | -35393000 | 131.85 |
| net change in cash | 21403000 | -83694000 | 125.57 |
| cash at end of period | 35527000 | 14124000 | 151.54 |
| cash at beginning of period | 14124000 | 97818000 | -85.56 |
Net Change in Cash: Net Change in Cash increased to 21 million in 2024Q3 from -84 million in 2024Q2 representing a change of 125.57%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -3 million in 2024Q3 from -46 million in 2024Q2 representing a change of 93.04%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -7 million in 2024Q3 from -48 million in 2024Q2 representing a change of 84.61%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -4 million in 2024Q3 from -3 million in 2024Q2 representing a change of -57.4%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Receivables: Accounts Receivables decreased to -88 million in 2024Q3 from 24 million in 2024Q2 representing a change of -469.31%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 200.0%. This indicates that the company's tax liability for future periods has increased.
Stock-Based Compensation: Stock-Based Compensation increased to 3 million in 2024Q3 from 2 million in 2024Q2 representing a change of 51.11%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 5 million in 2024Q3 from 3 million in 2024Q2 representing a change of 51.69%. This indicates that the company has increased its outstanding obligations to its suppliers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 79.06 | 74.8 | 5.70 |
| net income per share | -6.81 | -44.57 | 84.73 |
| operating cash flow per share | 11.75 | 7.21 | 62.87 |
| free cash flow per share | 10.27 | 5.61 | 82.97 |
| cash per share | 9.77 | 1.95 | 401.28 |
| book value per share | 43.66 | 70.07 | -37.69 |
| tangible book value per share | 0.98 | 10.79 | -90.92 |
| shareholders equity per share | 24.86 | 37.66 | -33.99 |
| interest debt per share | 61.66 | 68.22 | -9.61 |
| market cap | 123955280 | 88250250 | 40.46 |
| enterprise value | 625497280 | 629207250 | -0.59 |
| pe ratio | -1.96 | -0.23 | -735.74 |
| price to sales ratio | 0.17 | 0.14 | 20.77 |
| pocfratio | 1.14 | 1.45 | -21.62 |
| pfcf ratio | 1.3 | 1.86 | -30.23 |
| pb ratio | 0.54 | 0.28 | 93.38 |
| ptb ratio | 0.54 | 0.28 | 93.38 |
| ev to sales | 0.85 | 1.0 | -14.53 |
| enterprise value over ebitda | 16.17 | -3.61 | 547.61 |
| ev to operating cash flow | 5.73 | 10.33 | -44.53 |
| ev to free cash flow | 6.56 | 13.28 | -50.62 |
| earnings yield | -0.51 | -4.26 | 88.03 |
| free cash flow yield | 0.77 | 0.54 | 43.33 |
| debt to equity | 2.18 | 1.63 | 33.56 |
| debt to assets | 0.34 | 0.31 | 7.34 |
| net debt to ebitda | 12.97 | -3.11 | 517.46 |
| current ratio | 1.29 | 1.56 | -17.55 |
| interest coverage | -1.18 | -4.93 | 76.13 |
| income quality | -1.73 | -0.16 | -966.26 |
| dividend yield | 0.03 | 0 | NaN |
| payout ratio | -0.06 | 0 | NaN |
| sales general and administrative to revenue | 0.13 | 0.18 | -31.33 |
| research and ddevelopement to revenue | 0 | -0.0 | 100.00 |
| intangibles to total assets | 0.26 | 0.3 | -12.35 |
| capex to operating cash flow | 0.13 | 0.22 | -43.29 |
| capex to revenue | 0.02 | 0.02 | -12.62 |
| capex to depreciation | 0.13 | 0.13 | 2.83 |
| stock based compensation to revenue | 0.03 | 0.04 | -38.07 |
| graham number | 61.71 | 194.34 | -68.25 |
| roic | -0.11 | -0.34 | 66.92 |
| return on tangible assets | -0.06 | -0.32 | 82.35 |
| graham net net | -34.35 | -94.23 | 63.55 |
| working capital | 106427000 | 149101000 | -28.62 |
| tangible asset value | 9099000 | 91090000 | -90.01 |
| net current asset value | -617477000 | -653033000 | 5.44 |
| invested capital | 551819000 | 696477000 | -20.77 |
| average receivables | 626223000 | 313219000 | 99.93 |
| average payables | 136804000 | 140587000 | -2.69 |
| average inventory | 0 | 0 | NaN |
| days sales outstanding | 453.07 | 196.75 | 130.28 |
| days payables outstanding | 313.28 | 266.78 | 17.43 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.81 | 1.86 | -56.57 |
| payables turnover | 1.17 | 1.37 | -14.84 |
| inventory turnover | 0 | 0 | NaN |
| roe | -0.27 | -1.18 | 76.86 |
| capex per share | 1.48 | 1.6 | -7.64 |
ROE: Return on Equity (ROE) increased to -0.27 on 2023-12-31 from -1.18 on 2022-12-31, representing a change of 76.86%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -1.96 on 2023-12-31 from -0.23 on 2022-12-31, representing a change of -735.74%. Indicating a decrease in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 2.18 on 2023-12-31 from 1.63 on 2022-12-31, representing a change of 33.56%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.
Current Ratio: Current Ratio decreased to 1.29 on 2023-12-31 from 1.56 on 2022-12-31, representing a change of -17.55%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| GOCO | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 11.74 | 10.62 | 10.58 |
| net income per share | 1.52 | -2.61 | 158.50 |
| operating cash flow per share | -0.31 | -4.57 | 93.11 |
| free cash flow per share | -0.74 | -4.84 | 84.77 |
| cash per share | 3.53 | 1.42 | 148.94 |
| book value per share | 21.04 | 32.87 | -35.98 |
| tangible book value per share | -11.31 | -2.18 | -419.15 |
| shareholders equity per share | 21.04 | 20.33 | 3.51 |
| interest debt per share | 53.8 | 47.76 | 12.66 |
| market cap | 94522260.0 | 104118120 | -9.22 |
| enterprise value | 582055260 | 636098120 | -8.50 |
| pe ratio | 1.54 | -1.0 | 253.59 |
| price to sales ratio | 0.8 | 0.98 | -18.75 |
| pocfratio | -29.81 | -2.29 | -1204.12 |
| pfcf ratio | -12.73 | -2.16 | -490.07 |
| pb ratio | 0.45 | 0.51 | -13.20 |
| ptb ratio | 0.45 | 0.51 | -13.20 |
| ev to sales | 4.92 | 6.01 | -18.10 |
| enterprise value over ebitda | -13.64 | -44.45 | 69.31 |
| ev to operating cash flow | -183.56 | -13.96 | -1214.47 |
| ev to free cash flow | -78.4 | -13.18 | -494.75 |
| earnings yield | 0.16 | -0.25 | 165.11 |
| free cash flow yield | -0.08 | -0.46 | 83.05 |
| debt to equity | 2.47 | 2.26 | 9.15 |
| debt to assets | 0.39 | 0.36 | 7.00 |
| net debt to ebitda | -11.43 | -37.17 | 69.26 |
| current ratio | 1.18 | 1.29 | -7.94 |
| interest coverage | -2.24 | -2.24 | 0.37 |
| income quality | 0.11 | 1.75 | -93.98 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.14 | 0.15 | -6.45 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.24 | 0.28 | -12.58 |
| capex to operating cash flow | -1.34 | -0.06 | -2161.11 |
| capex to revenue | 0.04 | 0.03 | 40.87 |
| capex to depreciation | 0.16 | 0.1 | 56.69 |
| stock based compensation to revenue | 0.02 | 0.02 | 35.24 |
| graham number | 26.87 | 34.53 | -22.18 |
| roic | -0.06 | -0.06 | 5.40 |
| return on tangible assets | 0.02 | -0.03 | 152.84 |
| graham net net | -41.2 | -29.46 | -39.86 |
| working capital | 52072000 | 67134000 | -22.44 |
| tangible asset value | -113971000 | -21727000 | -424.56 |
| net current asset value | -795070000 | -628104000 | -26.58 |
| invested capital | 428950000 | 466503000 | -8.05 |
| average receivables | 866553500 | 840437000 | 3.11 |
| average payables | 56788500 | 99480500 | -42.91 |
| average inventory | 0 | 0 | NaN |
| days sales outstanding | 688.24 | 704.33 | -2.28 |
| days payables outstanding | 58.5 | 188.31 | -68.93 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.13 | 0.13 | 2.34 |
| payables turnover | 1.54 | 0.48 | 221.87 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.07 | -0.13 | 156.51 |
| capex per share | 0.42 | 0.27 | 55.78 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 1.54 on 2024-09-30 Q3 from -1.00 on 2024-06-30 Q2, representing a change of 253.59%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.18 on 2024-09-30 Q3 from 1.29 on 2024-06-30 Q2, representing a change of -7.94%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 2.47 on 2024-09-30 Q3 from 2.26 on 2024-06-30 Q2, representing a change of 9.15%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-09 04:37:50
GoHealth, Inc. (NASDAQ:GOCO ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants John Shave - Vice President, Investor Relation Vijay Kotte - Chief Executive Officer Brendan Shanahan - Chief Financial Officer Conference Call Participants Patrick McCann - Noble Capital Markets Ben Hendrix - RBC Capital Markets Robert McGuire - Granite Research James Sidoti - Sidoti Operator Good morning and welcome to GoHealth's Third Quarter 2024 Earnings Conference Call. My name is Hope, and I will be your operator for today's call.
Sentiment: Negative
Publish Date: 2024-11-07 09:45:38
GoHealth (GOCO) came out with a quarterly loss of $3.73 per share versus the Zacks Consensus Estimate of a loss of $3.19. This compares to loss of $2.61 per share a year ago.
Sentiment: Neutral
Publish Date: 2024-11-07 07:00:00
CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2024.
Sentiment: Neutral
Publish Date: 2024-10-17 16:00:00
CHICAGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- GoHealth Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”) today announced Vijay Kotte, CEO of GoHealth, will present at the LD Micro Main Event Investor Conference on Tuesday, October 29th, 2024, at The Luxe Sunset Boulevard, Los Angeles, CA. The Company's presentation is scheduled to begin at 3:00 pm CT. The presentation will be webcast. Register to watch the virtual presentation here GOCO Investor Presentation at LD Micro Main Event.
Sentiment: Neutral
Publish Date: 2024-10-10 09:00:00
GoHealth appoints Brendan Shanahan as Chief Financial Officer. Mr. Shanahan is a seasoned executive with over 30 years of financial leadership experience.
Sentiment: Positive
Publish Date: 2024-09-04 13:49:50
Health insurance marketplace GoHealth has inked an agreement to buy Medicare-focused e-TeleQuote. The acquisition is expected to close Sept.
Sentiment: Positive
Publish Date: 2024-09-04 07:00:00
CHICAGO and CLEARWATER, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace, today announced that it entered into a purchase and subscription agreement which will ultimately lead to the acquisition of e-TeleQuote Insurance, Inc., a distinguished name in the Medicare insurance marketplace.
Sentiment: Neutral
Publish Date: 2024-08-29 16:15:00
CHICAGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- GoHealth Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”) today announced it will be featured as a presenting company at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held on September 9-11, 2024. The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison Avenue. Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed or available on-demand.
Sentiment: Neutral
Publish Date: 2024-08-20 12:16:00
GoHealth, Inc. hosts ALMIA Medicare Conference with senior healthcare leaders, brokers and policymakers in lead up to the 2025 Annual Enrollment Period.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
